Exalenz Bioscience’s BreathID(R) Hp and BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients

Important new testing option for an infection that impacts nearly 20 million U.S. children and may have significant negative impacts on long-term health

MODI'IN, Israel and MANASQUAN, N.J., March 13, 2018 -- (Healthcare Sales & Marketing Network) -- Exa... Diagnostics, FDA Exalenz Bioscience, BreathID, Helicobacter pylori, H. pylori

Source: HSMN NewsFeed - March 13, 2018 Category: Pharmaceuticals Source Type: news